Docetaxel or its derivatives

including but not limited to cabazitaxel

Approval Date: December 19, 2013

Schedule: I

Footnote: PDL

Canadian Pharmacy Regulatory Authorities:

Contact

130 Albert Street, Suite 1800
Ottawa, Ontario K1P 5G4 Canada

Phone: 1 (613) 569-9658
info@napra.ca

Receive NAPRA updates of interest directly to your inbox: general NAPRA news, NDS updates and/or updates on practice resources.